<code id='00916A7C3D'></code><style id='00916A7C3D'></style>
    • <acronym id='00916A7C3D'></acronym>
      <center id='00916A7C3D'><center id='00916A7C3D'><tfoot id='00916A7C3D'></tfoot></center><abbr id='00916A7C3D'><dir id='00916A7C3D'><tfoot id='00916A7C3D'></tfoot><noframes id='00916A7C3D'>

    • <optgroup id='00916A7C3D'><strike id='00916A7C3D'><sup id='00916A7C3D'></sup></strike><code id='00916A7C3D'></code></optgroup>
        1. <b id='00916A7C3D'><label id='00916A7C3D'><select id='00916A7C3D'><dt id='00916A7C3D'><span id='00916A7C3D'></span></dt></select></label></b><u id='00916A7C3D'></u>
          <i id='00916A7C3D'><strike id='00916A7C3D'><tt id='00916A7C3D'><pre id='00916A7C3D'></pre></tt></strike></i>

          knowledge

          knowledge

          author:entertainment    Page View:64
          Five people put coins in a box containing coins and cash on stage — coverage from STAT
          Adobe

          In the United States, health care costs are so out of control that medical crowdfunding has become commonplace. The idea is simple: turn your social network into a financial safety net to cover the cost of expensive treatments or long illnesses. Millions of Americans have started crowdfunding campaigns for medical bills, and tens of millions have donated to them, mostly through the undisputed sector leader, GoFundMe.

          Nora Kenworthy, a nursing and health studies professor at the University of Washington, Bothell, has spent years studying the world of crowdfunding for health care — along with the way it ends up amplifying the inequities that already dictate who goes into medical debt.

          advertisement

          In her new book, “Crowded Out: The True Costs of Crowdfunding Healthcare,” which will be released on Tuesday, she looks at what she calls the “toxicities” that drive medical crowdfunding campaigns. STAT spoke with Kenworthy about those issues, as well as the difficult moral decisions potential donors face when deciding whether to contribute. The following interview is condensed and edited for clarity.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Republican states more likely to report Covid vaccine side effects
          Republican states more likely to report Covid vaccine side effects

          AdobePeopleinRepublican-votingstatesweremorelikelytoreportadverseeventsafterreceivingaCovid-19vaccin

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Trial using CRISPR to edit HIV out of cells disappoints

          AdobeBALTIMORE—AnambitiousefforttocureHIVwithCRISPRgenomeeditingfellshortinanearlyclinicaltrial,inve